technology for social impact MJN neuroserveis

TECHNOLOGY FOR SOCIAL IMPACT

We share a mission

Improve the quality of life of the people

We are an interdisciplinary group that works to make technologies that provide a better quality of life to the people. Our motivation is people, so we work hard to improve day by day with you. Get to know us.

David Blánquez

Founder, CEO-CTO

Salva Gutiérrez 

Founder, CEO-CFO

Xavier Raurich 

Founder, COO

Ernest Montañà 

Software engineer

Jesús Valls

Software engineer

Lluís Munsó

Software engineer

Jordina Arcal

Business development EU

Marta Arnau

Accounting

Fernando Atienza 

Quality manager

Anna Rodríguez

Sales manager

An unquestionable objective

We have very clear objectives.

We only understand technological development if it has a social impact, which is why we spend part of our income to R+D projects and part of our profits to social action.

MJN has a positive impact on our society, as we explain in our Theory of Social Change. Also, we will periodically measure our impact and publish the results obtained. Discover the importance of social change in MJN.

5

of our profit will be dedicated to promote social projects

10

of our sales will go to research and innovation
Our collaborators

We are not alone in our goal of helping people with epilepsy

Our collaborators

We are not alone helping people with epilepsy

This international certificate recognizes that MJN is compliant with all requirements specified to sell and provide medical products and services.

This certificate indicates that the solution developed by MJN to evaluate the risk of epilepsy seizures is a medical device that complies with directive 93/42/EEC.

Our commitment to excellence

Everything we do in MJN is compliant with the highest quality standards.

MJN has the ISO 13485:2016 quality certificate, the Manufacturer’s License from the Spanish Agency of Medicines and Health Products and the CE certificate as a class IIa medical device.

News

Discover the last company news

MJN Neuroserveis

Why invest in R&D?

When we started our project in 2012, we knew that only a highly advanced technological solution would be able to…
MJN Neuroserveis

MJN has obtained a grant for internationalization within the framework of the BRIDGEHEAD program of EIT Health

The EIT Health BRIDGEHEAD program aims to help health projects grow their businesses and validated products beyond the markets. BRIDGEHEAD…
MJN Neuroserveis

MJN obtains the EC medical device certification for its epilepsy aid solution

The MJN project was born with two main objectives. The first is to develop a technological solution to help people…
See all news

Do you imagine being able to know at any time the risk of suffering a seizure?

Awards and recognitions

Awards and recognitions

Grant programs

Horizon 2020, SME Instruments 2018-2020. Grant 849781

Project: Seizure Risk Asessment for epilepsy
See more

Retos Colaboración MJN-eXiT (Universitat de Girona)

Project: MJN-SERAS, Device for the evaluation of the risk of epileptic seizures

The main objective of the project is to improve the quality of life of patients with epilepsy through the development of a solution that will be capable of detecting and alerting epilepsy seizures suffered by this type of patient and thereby avoiding accidents resulting from these situations.

To achieve this objective, the project collaborates with the company MJN, which will take the lead into this initiative. The project will also count on the UDG eXiT Research Group who has a long experience in creating predictive methods from biomedical data.

Project funded by FEDER / Ministry of Science, Innovation, and Universities – State Research Agency / Project (RTC-2017-6701-1).

The main objective of this call is to promote technological development, innovation and quality research.

See more
Stories

From the people who best know about epiilepsy

A world of inspiration
Blog

We at MJN talk about epilepsy in all forums and all languages

Go to blog